Thank you for your question.
Certainly patients who don't have COVID-19 are becoming second-class patients. This effect has been demonstrated in almost all epidemics. There are many examples of this effect in West Africa. The people who experienced a decline in health or who died from a disease other than Ebola likely outnumbered the people who had Ebola.
Therefore, we must resume medical activities for patients who don't have COVID-19, including outpatient and inpatient services. This is where the idea of having hospitals for patients who test positive for COVID-19 and other hospitals for patients who test negative makes all the difference.
Patients who go to the hospital to receive treatment for cystic fibrosis wouldn't be exposed to COVID-19. They wouldn't be putting themselves at risk. For me, this is important. I'm telling everyone that we must start planning for the recovery period now and that we must learn to live with COVID-19.
We must consider the research capacity when the second wave will hit. We'll need to be innovative. We'll need to reorganize the tasks of the different medical communities. We'll probably need to ask residents and our medical students to work at a higher level.
We really must consider this. I suspect that not many plans are being made in this area today. We can't keep a health care system on hold forever. There would be collateral damage and avoidable situations that could have been prevented, such as the fact that patients' health would decline.
If you must emphasize one thing, that would be it.